Maven Securities’s GH Research GHRS Stock Holding History

Maven Securities’s Portfolio GHRS Stock Details GHRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-100,000	Closed	-$2.17M	–	1135
2021 Q2	$2.17M	Buy	+100,000	New	+$2.04M	0.09%	213

Other funds holding GHRS

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Maven Securities's GHRS Position: Q3 2021 in Review

Maven Securities sold out of GH Research (GHRS) in Q3 2021, closing a stake of 100,000 shares — an estimated $2.17M sold.

Maven Securities first reported a position in GHRS in Q2 2021 and held it in 1 quarter. The position peaked at $2.17M in Q2 2021. 30 funds tracked by Wall St. Rank hold GHRS as of Q3 2021.

Maven Securities reported no remaining GH Research position as of Q3 2021 after selling out during the quarter.
Maven Securities sold 100,000 GH Research shares in Q3 2021, an estimated $2.17M.
Maven Securities first reported a position in GH Research in Q2 2021 and held it in 1 quarter.
Maven Securities's GH Research position peaked at $2.17M in Q2 2021.
30 funds tracked by Wall St. Rank held GH Research as of Q3 2021.

Based on Maven Securities's 13F filing for Q3 2021, filed 15 Nov 2021.